Protective actions of ovarian hormones in the serotonin system of macaques

Frontiers in Neuroendocrinology

Volumn 30, Issue 2, 2009, Pages 212-238

  Bethea, Cynthia L ^a,b   Reddy, Arubala P ^a   Tokuyama, Yukari ^a   Henderson, Jessica A ^a   Lima, Fernanda B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Apoptosis; Apoptosis inducing factor; Estrogen; JNK1; Laser capture; Mitochondria; Neuroprotection; Progesterone; Serotonin; TUNEL

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN E; CYTOCHROME C; DNA; ESTROGEN; KYNURENINE MONOOXYGENASE; PLACEBO; PROGESTERONE; PROTEIN BCL 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SEX HORMONE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE; VASCULOTROPIN;

CELL CYCLE; CELL SURVIVAL; COGNITION; DNA FRAGMENTATION; DORSAL RAPHE NUCLEUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORMONE ACTION; HORMONE SUBSTITUTION; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LIFE STRESS; MACACA; MEDIAN RAPHE NUCLEUS; MENOPAUSAL SYNDROME; MENOPAUSE; MENTAL HEALTH; MICROARRAY ANALYSIS; MOOD DISORDER; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE PROJECTION; NEUROPROTECTION; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELL SURVIVAL; DNA FRAGMENTATION; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HORMONE REPLACEMENT THERAPY; HUMANS; LASERS; MACACA; MENOPAUSE; NEURONS; NEUROPROTECTIVE AGENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIECTOMY; PROGESTERONE; PROTO-ONCOGENE PROTEINS C-BCL-2; RAPHE NUCLEI; SEROTONIN;

EID: 67349138268     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yfrne.2009.04.003     Document Type: Review

References (141)

1. Adams J.H., Wigg K.G., King N., Burcescu I., Vetro A., Kiss E., Baji I., George C.J., Kennedy J.L., Kovacs M., and Barr C.L. Association study of neurotrophic tyrosine kinase receptor type 2 (NTRK2) and childhood-onset mood disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 132 (2005) 90-95
2. Almeida R.D., Manadas B.J., Melo C.V., Gomes J.R., Mendes C.S., Graos M.M., Carvalho R.F., Carvalho A.P., and Duarte C.B. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 12 (2005) 1329-1343
3. Becker E.B., and Bonni A. Cell cycle regulation of neuronal apoptosis in development and disease. Prog. Neurobiol. 72 (2004) 1-25
4. Becker E.B., and Bonni A. Beyond proliferation - cell cycle control of neuronal survival and differentiation in the developing mammalian brain. Semin. Cell Dev. Biol. 16 (2005) 439-448
5. Benedetti M.D., Maraganore D.M., Bower J.H., McDonnell S.K., Peterson B.J., Ahlskog J.E., Schaid D.J., and Rocca W.A. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov. Disord. 16 (2001) 830-837
6. Benninghoff J., Schmitt A., Mossner R., and Kesch K.-P. When cells become depressed: focus on neural stems cells in novel treatment strategies against depression. J. Neural Transm. 109 (2002) 947-962
7. Bethea C.L. Colocalization of progestin receptors with serotonin in raphe neurons of macaque. Neuroendocrinology 57 (1993) 1-6
8. Bethea C.L. Regulation of progestin receptors in raphe neurons of steroid-treated monkeys. Neuroendocrinology 60 (1994) 50-61
9. Bethea C.L., and Centeno M.L. Ovarian steroid treatment decreases corticotropin-releasing hormone (CRH) mRNA and protein in the hypothalamic paraventricular nucleus of ovariectomized monkeys. Neuropsychopharmacology 33 (2008) 546-556
10. Bethea C., and Reddy A. Effect of ovarian hormones on survival genes in laser captured serotonin neurons from macaques. J. Neurochem. 105 (2008) 1129-1143
11. Bethea C.L., Lu N.Z., Gundlah C., and Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front. Neuroendocrinol. 23 (2002) 41-100
12. Bethea C.L., Reddy A.P., and Smith L.J. Nuclear factor kappa B in the dorsal raphe of macaques: an anatomical link for steroids, cytokines and serotonin. J. Psychiat. Neurosci. 31 (2006) 105-114
13. Bethea C.L., Centeno M.L., and Cameron J.L. Neurobiology of stress-induced reproductive dysfunction in female macaques. Mol. Neurobiol. 38 (2008) 199-230
14. Biggio G., Follesa P., Sanna E., Purdy R.H., and Concas A. GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone. Int. Rev. Neurobiol. 46 (2001) 207-241
15. Bouchier-Hayes L., Conroy H., Egan H., Adrain C., Creagh E.M., MacFarlane M., and Martin S.J. CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways. J. Biol. Chem. 276 (2001) 44069-44077
16. Brinton R.D. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann. NY Acad. Sci. 1052 (2005) 57-74
17. Cervantes M., Gonzalez-Vidal M.D., Ruelas R., Escobar A., and Morali G. Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus. Arch. Med. Res. 33 (2002) 6-14
18. Chang G.Q., Hao Y., and Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 11 (1993) 595-605
19. Chiarugi A., Cozzi A., Ballerini C., Massacesi L., and Moroni F. Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. Neuroscience 102 (2001) 687-695
20. Chiarugi A., Meli E., and Moroni F. Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid. J. Neurochem. 77 (2001) 1310-1318
21. Chong Z.Z., Li F., and Maiese K. Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3. Curr. Neurovasc. Res. 3 (2006) 25-39
22. Christen S., Peterhans E., and Stocker R. Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc. Natl. Acad. Sci. USA 87 (1990) 2506-2510
23. Conti A.C., Raghupathi R., Trojanowski J.Q., and McIntosh T.K. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J. Neurosci. 18 (1998) 5663-5672
24. Corasaniti M.T., Amantea D., Russo R., Piccirilli S., Leta A., Corazzari M., Nappi G., and Bagetta G. 17beta-estradiol reduces neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. Neurotoxicology 26 (2005) 893-903
25. Cutler S.M., VanLandingham J.W., Murphy A.Z., and Stein D.G. Slow-release and injected progesterone treatments enhance acute recovery after traumatic brain injury. Pharmacol. Biochem. Behav. 84 (2006) 420-428
26. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13 (1999) 2905-2927
27. Davis A.S., Zhao H., Sun G.H., Sapolsky R.M., and Steinberg G.K. Gene therapy using SOD1 protects striatal neurons from experimental stroke. Neurosci. Lett. 411 (2007) 32-36
28. Deng Y., Lin Y., and Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 16 (2002) 33-45
29. Dhandapani K.M., Wade F.M., Wakade C., Mahesh V.B., and Brann D.W. Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFkappaB. J. Neurochem. 95 (2005) 9-19
30. Djebaili M., Guo Q., Pettus E.H., Hoffman S.W., and Stein D.G. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J. Neurotrauma 22 (2005) 106-118
31. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., and Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19 (1999) 6385-6393
32. Eastman C.L., and Guilarte T.R. Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line. Brain Res. 495 (1989) 225-231
33. 2O during hydroxylation of L-[3,5-3H]kynurenine. Anal. Biochem. 205 (1992) 257-262
34. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hogan P.E., Wallace R., Dailey M., Freeman R., and Hays J. Conjugated equine estrogens and global cognitive function in postmenopausal women: women's health initiative memory study. Jama 291 (2004) 2959-2968
35. Evan G., and Littlewood T. A matter of life and cell death. Science 281 (1998) 1317-1322
36. Faubel S., and Edelstein C.L. Caspases as drug targets in ischemic organ injury. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5 (2005) 269-287
37. Fuchs E., Czeh B., Kole M.H., Michaelis T., and Lucassen P.J. Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur. Neuropsychopharmacol. 14 Suppl. 5 (2004) S481-S490
38. Galani R., Hoffman S.W., and Stein D.G. Effects of the duration of progesterone treatment on the resolution of cerebral edema induced by cortical contusions in rats. Restor. Neurol. Neurosci. 18 (2001) 161-166
39. Garcia-Segura L.M., Cardona-Gomez P., Naftolin F., and Chowen J.A. Estradiol upregulates Bcl-2 expression in adult brain neurons. NeuroReport 9 (1998) 593-597
40. Garcia-Segura L.M., Azcoitia I., and DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63 (2001) 29-60
41. Garrido C., Galluzzi L., Brunet M., Puig P.E., Didelot C., and Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 13 (2006) 1423-1433
42. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119 (1992) 493-501
43. Gibson C.L., and Murphy S.P. Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. J. Cereb. Blood Flow Metab. 24 (2004) 805-813
44. Gonzalez-Vidal M.D., Cervera-Gaviria M., Ruelas R., Escobar A., Morali G., and Cervantes M. Progesterone: protective effects on the cat hippocampal neuronal damage due to acute global cerebral ischemia. Arch. Med. Res. 29 (1998) 117-124
45. Gora-Kupilas K., and Josko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol. 43 (2005) 31-39
46. Gray J., Yeo G., Hung C., Keogh J., Clayton P., Banerjee K., McAulay A., O'Rahilly S., and Farooqi I.S. Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. Int. J. Obes. (Lond) 31 (2007) 359-364
47. Green P.S., and Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18 (2000) 347-358
48. Guidetti P., Eastman C.L., and Schwarcz R. Metabolism of [5-3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway. J. Neurochem. 65 (1995) 2621-2632
49. Gundlah C., Lu N.Z., Mirkes S.J., and Bethea C.L. Estrogen receptor beta (ERb) mRNA and protein in serotonin neurons of macaques. Mol. Brain Res. 91 (2001) 14-22
50. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., and Davis R.J. Selective interaction of JNK protein kinase isoforms with transcription factors. Embo. J. 15 (1996) 2760-2770
51. Harms C., Lautenschlager M., Bergk A., Katchanov J., Freyer D., Kapinya K., Herwig U., Megow D., Dirnagl U., Weber J.R., and Hortnagl H. Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegeneration. J. Neurosci. 21 (2001) 2600-2609
52. Henderson V.W. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 138 (2006) 1031-1039
53. Henderson J.A., and Bethea C.L. Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques. Endocrine 33 (2008) 285-293
54. Henkel V., Baghai T.C., Eser D., Zill P., Mergl R., Zwanzger P., Schule C., Bottlender R., Jager M., Rupprecht R., Hegerl U., Moller H.J., and Bondy B. The gamma amino butyric acid (GABA) receptor alpha-3 subunit gene polymorphism in unipolar depressive disorder: a genetic association study. Am. J. Med. Genet. 126B (2004) 82-87
55. Herdegen T., Skene P., and Bahr M. The c-Jun transcription factor - bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci. 20 (1997) 227-231
56. Herrup K., Neve R., Ackerman S.L., and Copani A. Divide and die: cell cycle events as triggers of nerve cell death. J. Neurosci. 24 (2004) 9232-9239
57. Hoffman G.E., Merchenthaler I., and Zup S.L. Neuroprotection by ovarian hormones in animal models of neurological disease. Endocrine 29 (2006) 217-231
58. Honda K., Shimohama S., Sawada H., Kihara T., Nakamizo T., Shibasaki H., and Akaike A. Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J. Neurosci. Res. 64 (2001) 466-475
59. Hou S.T., Callaghan D., Fournier M.C., Hill I., Kang L., Massie B., Morley P., Murray C., Rasquinha I., Slack R., and MacManus J.P. The transcription factor E2F1 modulates apoptosis of neurons. J. Neurochem. 75 (2000) 91-100
60. Hou S.T., Cowan E., Walker T., Ohan N., Dove M., Rasqinha I., and MacManus J.P. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J. Neurochem. 78 (2001) 287-297
61. Isacson O. On neuronal health. Trends Neurosci. 16 (1993) 306-308
62. Ito Y., Saito K., Maruta K., Nakagami Y., Koike T., Oguri Y., and Nagamura Y. Kynurenine concentration of serum was increased by exercise. Adv. Exp. Med. Biol. 467 (1999) 717-722
63. Jaattela M., and Tschopp J. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4 (2003) 416-423
64. Jover-Mengual T., Zukin R.S., and Etgen A.M. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology 148 (2007) 1131-1143
65. Koh P.O. Estradiol prevents the injury-induced decrease of 90 ribosomal S6 kinase (p90RSK) and Bad phosphorylation. Neurosci. Lett. 412 (2007) 68-72
66. Konishi Y., and Bonni A. The E2F-Cdc2 cell-cycle pathway specifically mediates activity deprivation-induced apoptosis of postmitotic neurons. J. Neurosci. 23 (2003) 1649-1658
67. Koski C.L., Hila S., and Hoffman G.E. Regulation of cytokine-induced neuron death by ovarian hormones: involvement of antiapoptotic protein expression and c-JUN N-terminal kinase-mediated proapoptotic signaling. Endocrinology 145 (2004) 95-103
68. Krantic S., Mechawar N., Reix S., and Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci. 28 (2005) 670-676
69. Krantic S., Mechawar N., Reix S., and Quirion R. Apoptosis-inducing factor: a matter of neuron life and death. Prog. Neurobiol. 81 (2007) 179-196
70. Kumagae Y., Zhang Y., Kim O.J., and Miller C.A. Human c-Jun N-terminal kinase expression and activation in the nervous system. Brain Res. Mol. Brain Res. 67 (1999) 10-17
71. Lambert J.J., Belelli D., Peden D.R., Vardy A.W., and Peters J.A. Neurosteroid modulation of GABAA receptors. Prog. Neurobiol. 71 (2003) 67-80
72. Lavin M.F., and Kozlov S. ATM activation and DNA damage response. Cell Cycle 6 (2007) 931-942
73. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., and Herman B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366 (1998) 177-196
74. Liang Z.Q., Wang X., Li L.Y., Wang Y., Chen R.W., Chuang D.M., Chase T.N., and Qin Z.H. Nuclear factor-kappaB-dependent cyclin D1 induction and DNA replication associated with N-methyl-D-aspartate receptor-mediated apoptosis in rat striatum. J. Neurosci. Res. 85 (2007) 1295-1309
75. F.B. Lima, C.L. Bethea, Ovarian steroids decrease DNA fragmentation in serotonin neurons of non-injured rhesus macaques, Mol. Psychiat. (in press).
76. Lu N.Z., and Bethea C.L. Ovarian steroid regulation of 5HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27 (2002) 12-24
77. Lu T., Xu Y., Mericle M.T., and Mellgren R.L. Participation of the conventional calpains in apoptosis. Biochim. Biophys. Acta 1590 (2002) 16-26
78. Lu N.Z., Eshleman A.J., Janowsky A., and Bethea C.L. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution and function in female macaques. Mol. Psychiat. 8 (2003) 353-360
79. Lu A., Frink M., Choudhry M.A., Schwacha M.G., Hubbard W.J., Rue III L.W., Bland K.I., and Chaudry I.H. Mitochondria play an important role in 17beta-estradiol attenuation of H(2)O(2)-induced rat endothelial cell apoptosis. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E585-E593
80. Maggi A., Ciana P., Belcredito S., and Vegeto E. Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu. Rev. Physiol. 66 (2004) 291-313
81. Malina H.Z., and Martin X.D. Deamination of 3-hydroxykynurenine in bovine lenses: a possible mechanism of cataract formation in general. Graefes Arch. Clin. Exp. Ophthalmol. 233 (1995) 38-44
82. Malina H.Z., Richter C., Mehl M., and Hess O.M. Pathological apoptosis by xanthurenic acid, a tryptophan metabolite: activation of cell caspases but not cytoskeleton breakdown. BMC Physiol. 1 (2001) 7
83. Manji H.K., and Duman R.S. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol. Bull. 35 (2001) 5-49
84. Marcelain K., De La Torre C., Gonzalez P., and Pincheira J. Roles of nibrin and AtM/ATR kinases on the G2 checkpoint under endogenous or radio-induced DNA damage. Biol. Res. 38 (2005) 179-185
85. Marsden V.S., O'Connor L., O'Reilly L.A., Silke J., Metcalf D., Ekert P.G., Huang D.C., Cecconi F., Kuida K., Tomaselli K.J., Roy S., Nicholson D.W., Vaux D.L., Bouillet P., Adams J.M., and Strasser A. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419 (2002) 634-637
86. Martin L.J., Al-Abdulla N.A., Brambrink A.M., Kirsch J.R., Sieber F.E., and Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46 (1998) 281-309
87. McCullough L.D., Alkayed N.J., Traystman R.J., Williams M.J., and Hurn P.D. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 32 (2001) 796-802
88. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22 (1999) 105-122
89. Miramar M.D., Costantini P., Ravagnan L., Saraiva L.M., Haouzi D., Brothers G., Penninger J.M., Peleato M.L., Kroemer G., and Susin S.A. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J. Biol. Chem. 276 (2001) 16391-16398
90. Morita T., Saito K., Takemura M., Maekawa N., Fujigaki S., Fujii H., Wada H., Takeuchi S., Noma A., and Seishima M. L-tryptophan-kynurenine pathway metabolite 3-hydroxyanthranilic acid induces apoptosis in macrophage-derived cells under pathophysiological conditions. Adv. Exp. Med. Biol. 467 (1999) 559-563
91. Nishihara H., Kizaka-Kondoh S., Insel P.A., and Eckmann L. Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2. Proc. Natl. Acad. Sci. USA 100 (2003) 8921-8926
92. Okuda S., Nishiyama N., Saito H., and Katsuki H. 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J. Neurochem. 70 (1998) 299-307
93. Oo T.F., Blazeski R., Harrison S.M., Henchcliffe C., Mason C.A., Roffler-Tarlov S.K., and Burke R.E. Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J. Neurosci. 16 (1996) 6134-6145
94. Park D.S., Stefanis L., Yan C.Y., Farinelli S.E., and Greene L.A. Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells. J. Biol. Chem. 271 (1996) 21898-21905
95. Park S.Y., Tournell C., Sinjoanu R.C., and Ferreira A. Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons. Neuroscience 144 (2007) 119-127
96. Piantadosi C.A., Zhang J., Levin E.D., Folz R.J., and Schmechel D.E. Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp. Neurol. 147 (1997) 103-114
97. Post A., Crochemore C., Uhr M., Holsboer F., and Behl C. Differential induction of NF-kappaB activity and neural cell death by antidepressants in vitro. Eur. J. Neurosci. 12 (2000) 4331-4337
98. Ragonese P., D'Amelio M., and Savettieri G. Implications for estrogens in Parkinson's disease: an epidemiological approach. Ann. NY Acad. Sci. 1089 (2006) 373-382
99. Reddy A.P., and Bethea C.L. Preliminary array analysis reveals novel genes regulated by ovarian steroids in the monkey raphe region. Psychopharmacology (Berl) 180 (2005) 125-140
100. Rink A., Fung K.M., Trojanowski J.Q., Lee V.M., Neugebauer E., and McIntosh T.K. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am. J. Pathol. 147 (1995) 1575-1583
101. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28 (2003) 139-168
102. Saito K., and Heyes M.P. Kynurenine pathway enzymes in brain. Properties of enzymes and regulation of quinolinic acid synthesis. Adv. Exp. Med. Biol. 398 (1996) 485-492
103. Saito A., Hayashi T., Okuno S., Nishi T., and Chan P.H. Oxidative stress is associated with XIAP and Smac/DIABLO signaling pathways in mouse brains after transient focal cerebral ischemia. Stroke 35 (2004) 1443-1448
104. Sanchez R.L., Reddy A.P., Centeno M.L., Henderson J.A., and Bethea C.L. A second tryptophan hydroxylase isoform, TPH-2 mRNA, is increased by ovarian steroids in the raphe region of macaques. Brain Res. Mol. Brain Res. 135 (2005) 194-203
105. Schauwecker P.E. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background. Brain Res. 884 (2000) 116-128
106. Schmidt P.J., Nieman L., Danaceau M.A., Tobin M.B., Roca C.A., Murphy J.H., and Rubinow D.R. Estrogen replacement in perimenopause-related depression: a preliminary report. Am. J. Obstet. Gynecol. 183 (2000) 414-420
107. Schumacher M., Guennoun R., Stein D.G., and De Nicola A.F. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol. Ther. 116 (2007) 77-106
108. Scorrano L., Ashiya M., Buttle K., Weiler S., Oakes S.A., Mannella C.A., and Korsmeyer S.J. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell 2 (2002) 55-67
109. Sharma K., and Mehra R.D. Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax. Brain Res. 1204 (2008) 1-15
110. Shimura H., Schlossmacher M.G., Hattori N., Frosch M.P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K.S., and Selkoe D.J. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293 (2001) 263-269
111. Simpkins J.W., Yang S.H., Wen Y., and Singh M. Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies. Cell. Mol. Life Sci. 62 (2005) 271-280
112. Singer C.A., Rogers K.L., and Dorsa D.M. Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. NeuroReport 9 (1998) 2565-2568
113. Singh M., Sumien N., Kyser C., and Simpkins J.W. Estrogens and progesterone as neuroprotectants: what animal models teach us. Front. Biosci. 13 (2008) 1083-1089
114. Smith L.J., Henderson J.A., Abell C.W., and Bethea C.L. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 29 (2004) 2035-2045
115. Soustiel J.F., Palzur E., Nevo O., Thaler I., and Vlodavsky E. Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury. J. Neurotrauma 22 (2005) 345-352
116. Springer J.E. Apoptotic cell death following traumatic injury to the central nervous system. J. Biochem. Mol. Biol. 35 (2002) 94-105
117. Stone T.W. Endogenous neurotoxins from tryptophan. Toxicon 39 (2001) 61-73
118. Stone T.W., Mackay G.M., Forrest C.M., Clark C.J., and Darlington L.G. Tryptophan metabolites and brain disorders. Clin. Chem. Lab. Med. 41 (2003) 852-859
119. Suzuki S., Brown C.M., and Wise P.M. Mechanisms of neuroprotection by estrogen. Endocrine 29 (2006) 209-215
120. Tan Y., Wu C., De Veyra T., and Greer P.A. Ubiquitous calpains promote both apoptosis and survival signals in response to different cell death stimuli. J. Biol. Chem. 281 (2006) 17689-17698
121. Tatton W.G., Chalmers-Redman R., Brown D., and Tatton N. Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 53 Suppl. 3 (2003) S61-S70 discussion S70-S72
122. Teeling J.L., and Perry V.H. Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience 158 (2009) 1062-1073
123. Tejani-Butt S.M., Yang J., and Pawlyk A.C. Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus. NeuroReport 6 (1995) 1207-1210
124. Toborek M., Son K.W., Pudelko A., King-Pospisil K., Wylegala E., and Malecki A. ERK 1/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons. J. Cell. Biochem. 100 (2007) 279-292
125. Tokuyama Y., Reddy A., and Bethea C. Neuroprotective actions of ovarian hormones without insult in the raphe region of rhesus macaques. Neuroscience 154 (2008) 720-731
126. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., and Vaux D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102 (2000) 43-53
127. Vilatoba M., Eckstein C., Bilbao G., Frennete L., Eckhoff D.E., and Contreras J.L. 17beta-estradiol differentially activates mitogen-activated protein-kinases and improves survival following reperfusion injury of reduced-size liver in mice. Transplant. Proc. 37 (2005) 399-403
128. Wafford K.A., Macaulay A.J., Fradley R., O'Meara G.F., Reynolds D.S., and Rosahl T.W. Differentiating the role of gamma-aminobutyric acid type A (GABAA) receptor subtypes. Biochem. Soc. Trans. 32 (2004) 553-556
129. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15 (2001) 2922-2933
130. Wei H., Leeds P., Chen R.W., Wei W., Leng Y., Bredesen D.E., and Chuang D.M. Neuronal apoptosis induced by pharmacological concentrations of 3-hydroxykynurenine: characterization and protection by dantrolene and Bcl-2 overexpression. J. Neurochem. 75 (2000) 81-90
131. Wei L., Ying D.J., Cui L., Langsdorf J., and Yu S.P. Necrosis, apoptosis and hybrid death in the cortex and thalamus after barrel cortex ischemia in rats. Brain Res. 1022 (2004) 54-61
132. Won C.K., Ha S.J., Noh H.S., Kang S.S., Cho G.J., Choi W.S., and Koh P.O. Estradiol prevents the injury-induced decrease of Akt activation and Bad phosphorylation. Neurosci. Lett. 387 (2005) 115-119
133. Wu T.W., Wang J.M., Chen S., and Brinton R.D. 17Beta-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 135 (2005) 59-72
134. Xu X., Raber J., Yang D., Su B., and Mucke L. Dynamic regulation of c-Jun N-terminal kinase activity in mouse brain by environmental stimuli. Proc. Natl. Acad. Sci. USA 94 (1997) 12655-12660
135. Yang H.S., Jansen A.P., Nair R., Shibahara K., Verma A.K., Cmarik J.L., and Colburn N.H. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 20 (2001) 669-676
136. Yao M., Nguyen T.V., and Pike C.J. Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death. J. Neurosci. 27 (2007) 1422-1433
137. Zhang Y., and Bhavnani B.R. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. BMC Neurosci. 6 (2005) 13
138. Zhang Y., Lu X., and Bhavnani B.R. Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death. BMC Neurosci. 4 (2003) 32
139. Zhao L., Wu T.W., and Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010 (2004) 22-34
140. Zhao L., O'Neill K., and Diaz Brinton R. Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Res. Brain Res. Rev. 49 (2005) 472-493
141. Zhu Z.H., Yang R., Fu X., Wang Y.Q., and Wu G.C. Astrocyte-conditioned medium protecting hippocampal neurons in primary cultures against corticosterone-induced damages via PI3-K/Akt signal pathway. Brain Res. 1114 (2006) 1-10